20 results
8-K
EX-10.2
LRMR
Larimar Therapeutics Inc
21 May 21
Entry into a Material Definitive Agreement
9:30am
to review and oversee any registration or matters pursuant to this Section 2(e), including participation in any meetings or discussions with the SEC
8-K
EX-10.2
LRMR
Larimar Therapeutics Inc
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
is an “underwriter.” The Investors shall have the right to select one legal counsel to review and oversee any registration or matters pursuant to thisSection 2
PRE 14A
LRMR
Larimar Therapeutics Inc
12 Apr 24
Preliminary proxy
6:06am
responsibility for the risk management process, including monitoring and assessing strategic risk exposure, its Committees oversee risk in certain … and avoiding litigation abuse resulting from the current disparity that exists in the treatment of directors, who oversee and are ultimately accountable
8-K
EX-10.3
y3gup0y
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K
EX-1.1
86jiho1yv2
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
8-K
EX-1.1
3ffzi1
16 Feb 24
Entry into a Material Definitive Agreement
4:06pm
PRER14A
xog83
10 Apr 20
Preliminary revised proxy
4:38pm
PREM14A
mysqjxec3z10ev 5v0g
6 Mar 20
Preliminary proxy related to merger
5:32pm
DEFM14A
x6pqmb 58
29 Apr 20
Proxy related to merger
3:20pm
- Prev
- 1
- Next